# Breath Analysis Based Disease Biomarkers

> **NCT04341012** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 46 (actual)

## Conditions studied

- Liver Diseases
- Liver Cancer
- COVID19

## Interventions

- **DIAGNOSTIC_TEST:** Collection of breath sample

## Key facts

- **NCT ID:** NCT04341012
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-10
- **Primary completion:** 2021-09-03
- **Final completion:** 2021-09-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341012, "Breath Analysis Based Disease Biomarkers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04341012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*